Vascular complications in transcatheter aortic valve replacement with plug-based versus suture-based closure devices.
暂无分享,去创建一个
Y. Arbel | A. Steinvil | A. Halkin | S. Banai | Jeremy Ben-Shoshan | A. Finkelstein | Samuel Bazan | D. Zahler | T. Itach | L. Zornitzki | S. Frydman | Maayan Konigstein
[1] S. Waxman,et al. Comparison of Suture-Based and Collagen-Based Vascular Closure Devices for Large Bore Arteriotomies—A Meta-Analysis of Bleeding and Vascular Outcomes , 2022, Journal of cardiovascular development and disease.
[2] A. Steinvil,et al. Temporal Trends of Transcatheter Aortic Valve Implantation over 12 Years: A High-Volume Single-Center Experience , 2022, Journal of clinical medicine.
[3] A. Goldsweig,et al. MANTA Versus Suture-based Closure Devices Following Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis , 2022, Journal of the Society for Cardiovascular Angiography & Interventions.
[4] H. Thiele,et al. Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial , 2021, Circulation.
[5] P. Simon,et al. Vascular Complications in TAVR: Incidence, Clinical Impact, and Management , 2021, Journal of clinical medicine.
[6] H. Thiele,et al. Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center. , 2021, Cardiovascular revascularization medicine : including molecular interventions.
[7] P. D. de Jaegere,et al. Suture- or Plug-Based Large-Bore Arteriotomy Closure: A Pilot Randomized Controlled Trial. , 2020, JACC. Cardiovascular interventions.
[8] Brian C. Case,et al. Real-world experience of the MANTA closure device: Insights from the FDA manufacturer and user facility device experience (MAUDE) database. , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[9] K. Epps,et al. Incidence, prognosis and predictors of major vascular complications and percutaneous closure device failure following contemporary percutaneous transfemoral transcatheter aortic valve replacement. , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[10] R. Kobza,et al. Insights From a Multidisciplinary Introduction of the MANTA Vascular Closure Device. , 2019, JACC. Cardiovascular interventions.
[11] M. Laine,et al. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[12] I. Barbash,et al. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry , 2018, Clinical Research in Cardiology.
[13] M. Niemelä,et al. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. , 2018, International journal of cardiology.
[14] R. D. de Winter,et al. Incidence, Predictors, and Impact of Vascular Complications After Transfemoral Transcatheter Aortic Valve Implantation With the SAPIEN 3 Prosthesis. , 2018, The American journal of cardiology.
[15] A. Colombo,et al. Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study. , 2017, JACC. Cardiovascular interventions.
[16] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[17] P. Serruys,et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. , 2012, American Journal of Cardiology.
[18] J. Bavaria,et al. Clinical ResearchInterventional CardiologyVascular Complications After Transcatheter Aortic Valve Replacement: Insights From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial , 2012 .
[19] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.